secwatch.observer — SEC 8-K summary
======================================

Issuer:     CNBX Pharmaceuticals Inc. (CNBX)
CIK:        0001343009
Form:       8-K
Filed at:   2022-12-29T23:59:59+00:00
Accession:  0001683168-22-008672
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Shaul Yemal resigns from CNBX Pharmaceuticals board effective Dec 25, 2022
--------------------------------------------------------------------------------

- Shaul Yemal resigned as Director and Board Member on December 25, 2022.
- Resignation was not due to any dispute with the company.
- No replacement named; board vacancy remains.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1343009/000168316822008672/0001683168-22-008672-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1343009/000168316822008672/cnbx_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-22-008672

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer